We investigated the presence of a single-nucleotide polymorphism designated 
We investigated the presence of a single-nucleotide polymorphism designated are widely spread around the world, and with their high rate of coinfection, these viruses continue to cause increased mortality, especially among people who inject drugs (PWID). In addition to sociodemographic factors, host genetics might influence susceptibility to these viruses. [1] [2] [3] [4] As interferon-λs (IFNλs), and interferons in general, are essential in innate immune responses, polymorphisms located in these genes are of interest.
The IFNλs induce a variety of biological activities similar to type I interferons, including antiviral activity. 5 IFNλs activate the Jak-STAT pathway via the heterodimeric receptor including the chains of IFNλR1 and interleukin-10R2 and upregulate interferon stimulated genes. 6, 7 The expression of the IFNλR1 is limited to hepatocytes, cells of myeloid lineage, and epithelial cells of the lung, intestine, and skin. 6, 8 Indeed, IFNλs are essential to fighting viral respiratory infections 8 and IFNλs have been shown to successfully inhibit HCV and HIV replication in vitro. 6 In HCV infection, genome-wide association studies have shown that the single-nucleotide polymorphism rs12979860 (also referred to as interleukin-28B rs12979860 polymorphism), located in the IFNλ4 gene, influences the outcome of interferon-based therapy and spontaneous HCV clearance. 9, 10 Persons with the IFNλ4 rs12979860
C allele have higher probability of achieving sustained virologic response compared with persons without this allele when receiving interferon-based therapy. 9 The same allele is also responsible for a higher rate of spontaneous viral elimination of HCV. 11, 12 Few studies have evaluated the effect of IFNλ4 rs12979860 polymorphism on HIV disease progression by comparing typical 
| MATERIALS AND METHODS
A cross-sectional study was conducted among Caucasian PWID and blood donors. The study group included 345 PWID who were recruited using the respondent-driven sampling method from a syringe exchange programme in Tallinn, Estonia, in 2011. 16 HIV, HCV, and hepatitis B virus (HBV) serostatuses were determined as described previously. 1 To detect IFNλ4 rs12979860, DNA was extracted using a Pure-Link Pro 96 Genomic DNA Purification Kit (Invitrogen, Carlsbad, CA), and the genotyping was done using allelic discrimination analysis with the following primers and probes:
5′-TGCCTGTGCTGTACTGAA-3′ (sense), 5′-GAGCGCGGAGTGCAAT TC-3′ (antisense), 5′-TCCCCGAAGGCGTGA-3′ (VIC-probe), and 5′-AAG GCGCGAACCA-3′ (FAM-probe) 17 and the ABI7900HT Sequence Detection System (Applied Biosystems, Foster City, CA).
| Statistical analyses
Statistical analyses were performed using the program R 2.13.1 (www.rproject.org) and Stata 14 (www.stata.com). Differences in the distributions of IFNλ4 genotypes between the groups were examined using Fisher exact test. Logistic regression analysis was used, and odds ratios (ORs) with corresponding 95% confidence interval (CI) were calculated to further assess the impact of IFNλ4 rs12979860 TT genotype on HIV positivity. To determine possible confounders to be included in multivariable logistic regression analysis, the software DAGitty version 2.3 was used (http://www.dagitty.net). 18 To explore statistical interaction, interaction term was included in the model, and marginal effects at representative values were calculated using predictions from this model. P values below 0.05 were considered to be significant.
| RESULTS
The majority of the PWID included in the study were male (79%), the In all groups IFNλ4 rs12979860 was in Hardy-Weinberg equilibrium with a TT genotype frequency ranging from 5% to 16% (Supplementary Information Table S1 ). TT genotype increased the probability of being HIV+ to a greater extent for people who had injected drugs for shorter periods of time.
The OR was largest when the duration of IVDU was less than 1 year (Table 3 ). Since we found no significant association between the IFNλ4 rs12979860 polymorphism and acquisition of HCV, this trend might be due to the association between IFNλ4 rs12979860 polymorphism and acquisition of HIV.
| DISCUSSION
To the best of our knowledge, this is the first study evaluating the T Comparison of these groups revealed no significant differences (all P > 0.05).
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In terms of HIV infection, the few reports investigating 21 The rs368234815ΔG variant creates a frame shift which results in the production of the IFNλ4 protein. 21 The rs368234815 TT/TT genotype, which marks the rs12979860 CC genotype, has been shown to be more frequent among highly exposed seronegative individuals compared to HIV+ subjects. This study has some limitations. First, the data on HCV viral load were not available, and thus we were unable to distinguish between patients with active and past HCV infections or whether the rs12979860 polymorphism affects spontaneous viral clearance in our population. Second, we had rather small groups of HIV−HCV− and HIV+HCV− PWID which might have resulted in lack of statistical power to detect any associations as for studied polymorphism and HIV and HCV serostatus-based groups. As PWID are very hard-toreach population it is difficult to recruit participants based on infection statuses. Third, as the HIV treatment information was collected through self-reported questionnaire we had no information with regard to the length or the combination of the treatment or the HIV viral load which prevented us to determine any associations between this polymorphism and HIV disease progression and/or treatment. Nevertheless, we believe the importance of our results is not diminished by these limitations.
In conclusion, the study results support our hypothesis as for the influence of the IFNλ4 rs12979860 polymorphism affecting the susceptibility to HIV infection but not as for the acquisition of HCV infection in a Caucasian PWID population.
